Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Grant of Share Options

26 Jul 2019 12:00

RNS Number : 8913G
PCI-PAL PLC
26 July 2019
 

 

PCI-PAL PLC

("PCI Pal", "the Company" or "the Group")

Grant of Share Options

 

PCI-PAL PLC (AIM: PCIP), the customer engagement specialist that secures and protects payment card data for companies handling payments by phone, today announces the grant ("Grant") of share options ("Options"), over a total of 300,000 ordinary shares of 1 pence each ("Ordinary Shares") to Hugh James, CTO of the Company and a person discharging managerial responsibilities ("PDMR").

The Grant replaces a grant for the same number of share options on the same terms made when Mr James joined the Group on 2 January 2019, which were not fully registered.

 

The details of the Grant are as follows:

Name

Title

No Share Options granted

Date of Grant

Earliest Vesting date

Hugh James

CTO

300,000

25/07/2019

2/01/2022

 

Terms of the Options

The terms and conditions of these options will match those originally granted to Mr James on 2 January 2019.

 

The exercise price is 19.0 pence per Ordinary Share being the closing mid-market price published by the London Stock Exchange on 2 January 2019 and the earliest vesting date is 2 January 2022, subject to the recipient having remained in continuous employment prior to any exercising of this Grant and subject to the conditions below:

 

Tranche of award

Vesting Criteria

150,000 Options

Shall vest if the price of an Ordinary Share is equal to or greater than the Exercise Price during any continuous 30 day period falling after the Date of Grant

 

75,000 Options

Shall vest if the price of an Ordinary Share is equal to or greater than the Exercise Price plus 50% (28.50 pence per ordinary share) during any continuous 30 day period falling after the Date of Grant

 

 

75,000 Options

Shall vest if the price of an Ordinary Share is equal to or greater than the Exercise Price plus 100% (38.0 pence per ordinary share) during any continuous 30 day period falling after the Date of Grant

 

 

Following this grant, Hugh James holds options over 300,000 Ordinary Shares and he does not hold any other Ordinary Shares in the Company.

 

Following this announcement, the Company has a total of 5,111,667 options over Ordinary Shares outstanding, representing approximately 11.97% of the current issued share capital of the Company.

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

 

finnCap (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks (Corporate Finance)

Richard Chambers (Corporate Broking)

 

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Paul Vann

+44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a specialist provider of secure payment solutions for contact centres and businesses taking Cardholder Not Present (CNP) payments. PCI Pal's globally accessible cloud platform empowers organisations to take payments securely without bringing their environments into scope of PCI DSS and other card payment data security rules and regulations.

 

With the entire product portfolio served from PCI Pal's cloud environment, integrations with existing telephony, payment, and desktop environments are light-touch, ensuring no degradation of service while achieving security and compliance.

 

PCI Pal has offices in London, Ipswich (UK) and Charlotte NC (USA). For more information visit www.pcipal.com or follow the team on Twitter:  https://twitter.com/PCIPAL

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Hugh James

2.

Reason for the notification

a)

Position/status:

CTO / PDMR

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

PCI PAL PLC

b)

LEI:

213800XTX34IQYMYES95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary shares of 1 pence each

 

ISIN Code: GB0009737155

b)

Nature of the transaction:

 Grant of Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

19.0 pence

300,000

 

d)

Aggregated information:

·; Aggregated volume:

·; Price:

N/A

e)

Date of the transaction:

25 July 2019

f)

Place of the transaction:

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFEIDEIRFIA
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.